Chirpstory will close the service later this year. At the end of September, you will not be able to post stories or comments.

Excellent Day3&4 Live-Tweeting at #ASCO17 #cancer #cancerresearch #Oncology @ASCO #PrecisionMedicine #liquidbiopsy ‏#genomics #PersonalizedMedicine #PrecisionOncology #ImmunoOnco #Immunotherapy #immunooncology #NGS #ASCO2017 #biomarkers #precisioncancerc

53rd AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING 2017 ASCO Annual Meeting 2017 Friday 2nd June 2017 - Tuesday 6th June 2017 Read More
0
Steven Cooper @scooperpr

Drugs score big wins against lung, prostate, breast cancers #ASCO2017 apnews.com/4748d50744f048…

05/06/2017 23:05:38 WIB
Susan Keown @sejkeown

My latest for @fredhutch- New drug knocks out 1 of defenses that make #pancreaticcancer so tough to treat #ASCO17 fredhutch.org/en/news/center…

05/06/2017 23:05:34 WIB
Mike Thompson, MD, PhD, FASCO @mtmdphd

. @ASCO Research Community Forum - Save the Date for 2017 September 24-25, 2017 Alexandria, VA #ASCOResearchForum

05/06/2017 23:05:28 WIB
CancerDotNet @CancerDotNet

ASCO's Dr. Daniel Hayes talks about new research on targeted therapy for BRCA-Related #breastcancer: bit.ly/ASCO17v3 #ASCO17 #bcsm pic.twitter.com/QyfYc0RJYg

05/06/2017 23:05:18 WIB
Expand pic
Tom Silver @TomSilver39

$NKTR #ASCO17 Nektar Presents New Clinical Data from Two Studies of NKTR-214, a CD122-Biased Agonist, at 2017 (ASCO) Annual Meeting pic.twitter.com/32lmNoqBxh

05/06/2017 23:05:16 WIB
Expand pic
OncLive.com @OncLive

ASCO 2017: Pembrolizumab Again Demonstrates Durable Activity in TNBC #bcsm #ASCO17 onclive.com/conference-cov…

05/06/2017 23:05:11 WIB
Conquer Cancer, the ASCO Foundation @ConquerCancerFd

Congrats @EthanBasch1 on presenting your abstract at #ASCO17. Thx to our donors for supporting researchers like him! bit.ly/2qOhPDJ

05/06/2017 23:05:06 WIB
Salutedomani @salutedomani

CARCINOMA UROTELIALE: PEMBROLIZUMAB MIGLIORA LA SOPRAVVIVENZA #ASCO17: Confermata l… goo.gl/fb/phml9L

05/06/2017 23:05:03 WIB
@QIAGEN_live @QIAGEN_live

New biomarkers for MSI & MMR to be added to QIAGEN’s next-generation sequencing assays #ASCO17: fal.cn/ulaq pic.twitter.com/V4qvrsmA5T

05/06/2017 23:05:03 WIB
Expand pic
Michael Fisch MD MPH @fischmd

Dr. Schrag raises 2 thorny issues in genomic testing: tracking outcomes for off-label use; cascade testing from germline findings #ASCO17

05/06/2017 23:04:35 WIB
Yale Cancer Center @YaleCancer

Updated results of a phase I study for metastatic #urothelial #cancer presented today by Dr. Dan Petrylak @YaleCancer #ASCO17 @ASCO

05/06/2017 23:04:31 WIB
Marco Maruzzo, MD PhD @marcodoc

Negative trial w pazopanib adjuvant for localized high risk RCC #ASCO17 #kidneycancer pic.twitter.com/LYc8afKUCn

05/06/2017 23:04:12 WIB
Expand pic
Jacob Plieth @JacobPlieth

CD19 CAR-T in r/r ALL from Innovative Cellular Therapeutics (Chinese group - remember them?). 26/30 CRs #ASCO17 pic.twitter.com/2AgBrgqVrI

05/06/2017 23:04:12 WIB
Expand pic
Physician Relations at MD Anderson Cancer Center @PhysRelations

Board 29 Abstract 2537 Hormone receptor (AR/ER/PR) expression as a prognostic marker & novel candidate for... @ASCO #ASCO17 @VivekSubbiah pic.twitter.com/WnYEMS0S0t

05/06/2017 23:04:08 WIB
Expand pic
Myriad Genetics @myriadgenetics

.@EndoPredictUSA will soon be covered for approx. 75% of breast cancer patients in the U.S. Learn more: goo.gl/FBGSVL #ASCO17 pic.twitter.com/OurBX23kbf

05/06/2017 23:04:03 WIB
UPMC @UPMCnews

Dr. James Lee from @UPMCnews discusses his poster on a study of pembrolizumab in metastatic #coloncancer. #ASCO17 pic.twitter.com/H4GQVIxShe

05/06/2017 23:03:59 WIB
Expand pic
Load Remaining (7169)

Comment